- Previous Close
3.1800 - Open
3.2200 - Bid 3.2000 x --
- Ask 3.2200 x --
- Day's Range
3.2000 - 3.2600 - 52 Week Range
3.2000 - 6.2739 - Volume
15,500 - Avg. Volume
0 - Market Cap (intraday)
1.932B - Beta (5Y Monthly) 0.26
- PE Ratio (TTM)
17.89 - EPS (TTM)
0.1800 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Apr 28, 2025
- 1y Target Est
--
Asian Phytoceuticals Public Company Limited engages in the research and development, manufacture, and distribution of healthcare and natural extracts-based beauty products in Thailand. The company offers slimming, anti-wrinkle and anti-spots, and skin care and nourishing products. It also provides fat reduction, healthcare, and health drink products, as well as dietary supplement products for pet care. The company distributes its products through call centers, sales agents, dropships, and various marketing channels. It also exports its products. The company was formerly known as Natural Cosmetics Research Co., Ltd. and changed its name to Asian Phytoceuticals Public Company Limited in July 2005. Asian Phytoceuticals Public Company Limited was founded in 1988 and is headquartered in Lamphun, Thailand.
www.apco.co.th--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: APCO-R.BK
View MorePerformance Overview: APCO-R.BK
Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: APCO-R.BK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: APCO-R.BK
View MoreValuation Measures
Market Cap
1.91B
Enterprise Value
1.58B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
25.95%
Return on Assets (ttm)
4.95%
Return on Equity (ttm)
9.52%
Revenue (ttm)
210.83M
Net Income Avi to Common (ttm)
54.71M
Diluted EPS (ttm)
0.1800
Balance Sheet and Cash Flow
Total Cash (mrq)
351.66M
Total Debt/Equity (mrq)
4.31%
Levered Free Cash Flow (ttm)
29.03M